David Patten in Thibodaux, Louisiana

Home Louisiana Thibodaux

David Patten has Pulmonary Disease as his primary medical specialty. Their primary office is: 602 N Acadia Rd in Thibodaux, Louisiana. There are 2 additional office locations for David Patten that can be viewed towards the end of their profile.

They're a part of the: Thibodaux Regional Network Development Corporation medical group which has around 96 members. You can call their office at 985-493-4750 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Utah School Of Medicine and graduated in 2007 (around 17 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

David Y Patten Office Phone and Directions

David Patten
Thibodaux Regional Network Development Corporation
602 N Acadia Rd
Thibodaux, Louisiana 70301
985-493-4750

Patient Ratings
Please rate your experience with David Patten below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 985-493-4750

Enter a starting address:

Healthcare Info for David Patten

Medical School: University Of Utah School Of Medicine
Graduation Year: 2007
The Primary Medical Specialty for David Patten is listed as: Pulmonary Disease
Approximate Years of Experience: 17
PAC (PECOS ID)#: 4587702915
NPI #: 1841463114
NPI Created On: 04/08/2008
NPI Last Updated Listed as: 07/05/2018
Primary Taxonomy Code: 390200000X
Listed Gender: Male

Procedures, Services, Charges

Services and Procedures include:

Removal of fluid from chest cavity with imaging guidance
Vaccine for influenza for injection into muscle
Pneumococcal vaccine for injection into muscle
Measurement and graphic recording of total and timed exhaled air capacity
Test for exercise-induced lung stress
Respiratory inhaled pressure or nonpressure treatment to relieve airway obstruction or for sputum specimen
Demonstration and/or evaluation of patient use of aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure breathing (ippb) device
Determination of lung volumes using plethysmography
Measurement of lung diffusing capacity
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 50 minutes per day
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Critical care delivery critically ill or injured patient, first 30-74 minutes

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $35

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787600641

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: Endo-Mechanical

Name of Drug #1: Monarch Platform

Payments Total: $27

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788742151

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiology

Name of Drug #1: UPTRAVI

Open Associated Drug #1: 66215-602-14

Payments Total: $10

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801603179

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801606665

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $2

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801609402

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $10

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802176079

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802246853

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802248365

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802331095

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802457379

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Additional Office Locations

1. Thibodaux Regional Network Development Corporation
602 N Acadia Rd
Thibodaux, LA 70301
Thibodaux Regional Pathology
Group Members: 96

Phone: 985-493-4750

Enter a starting address:

2. Thibodaux Regional Network Development Corporation
604 N Acadia Rd
Thibodaux, LA 70301
411 Thibodaux Regional Pulmonary And Critical Care Clin
Group Members: 96

Phone: 985-493-4750

Enter a starting address:

Pulmonary Disease Professionals in Thibodaux

1.
Ted Brady

604 N Acadia Rd
Thibodaux, LA
Thibodaux Regional Network Development Corporation

Providers in Thibodaux Regional Network Development Corporation

1.Clel Acosta

602 N Acadia Rd
Thibodaux La 70301-4823
Thibodaux Regional Network Development Corporation
Anesthesiology

2.Clel Acosta

602 N Acadia Rd
Thibodaux La 70301-4823
Thibodaux Regional Network Development Corporation
Anesthesiology

3.Troy Albert

602 N Acadia Rd
Thibodaux La 70301-4847
Thibodaux Regional Network Development Corporation
Certified Registered Nurse Anesthetist (crna)

4.Dwayne Andras Np

604 N Acadia Rd
Thibodaux La 70301-4851
Thibodaux Regional Network Development Corporation
Nurse Practitioner

5.Dwayne Andras Np

2595 Hwy 1
Labadieville La 70372-0000
Thibodaux Regional Network Development Corporation
Nurse Practitioner

6.Jessica Angerdina

602 N Acadia Rd
Thibodaux La 70301-4847
Thibodaux Regional Network Development Corporation
Certified Registered Nurse Anesthetist (crna)

View all 96 members of Thibodaux Regional Network Development Corporation medical group